603676.SHG Tibet Weixinkang Medicine Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
8.40 CNY
Close of Nov 4, 2026
7.82 11.88
Market cap
CNY 3.66B
P/E
19.1x
P/B
2.30x
ROE
15.0%
Dividend yield
4.47%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603676.SHG undervalued?

Graham number
Price8.40
Graham value6.02
Premium39.6%

603676.SHG trades 39.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tibet Weixinkang Medicine Co Ltd fundamental analysis

No fundamental analysis for Tibet Weixinkang Medicine Co Ltd yet.

Tibet Weixinkang Medicine Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tibet Weixinkang Medicine Co Ltd

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers APIs; multivitamins and pediatric multivitamins for injections; concentrate of trace elements solution for infusion; compound and pediatric compound amino acid injections; iron sucrose, multiple electrolytes, potassium aspartate and magnesium aspartate, carbohydrate and electrolyte, pentoxifylline, piracetam, and dopamin…

Full company profile